Shopping Cart 0
Cart Subtotal
USD 0

SPI Pharma Inc - Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

SPI Pharma Inc-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-GlobalData's summarization of the company's business strategy.

- SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

Highlights

SPI Pharma Inc (SPI Pharma), a subsidiary of SPI Holdings Inc. provides pharmaceutical ingredients and technologies for patient-friendly dosage forms. The company undertakes the manufacturing and marketing of various pharmaceutical products and technologies to solve challenging formulation problems. It offers a wide range of pharmaceuticals products which contain antacid actives, soluble excipients, taste-masking technology actives, vaccine adjuvants and drug delivery systems for oral dose applications. SPI Pharma offers products in various formulations such as chewables, lozenges, powders and other patient-friendly dosage forms such as swallow tablets, chewable tablets, fast dissolve tablets and soft gelatin capsules. The company also offers contract manufacturing services to other companies. It operates business through its manufacturing sites, research and development centers and sales offices located in the UK, Canada, China, France and India. SPI Pharma is headquartered in Wilmington, Delaware, the US.

SPI Pharma Inc Key Recent Developments

Oct 09,2018: SPI Pharma launches Mannogem XL mannitol, enabling production of difficult-to-compress and problematic formulations

Reasons to buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

SPI Pharma Inc-Key Facts 5

SPI Pharma Inc-Key Employees 6

SPI Pharma Inc-Major Products and Services 7

SPI Pharma Inc-History 10

SPI Pharma Inc-Company Statement 11

SPI Pharma Inc-Locations And Subsidiaries 12

Head Office 12

Other Locations & Subsidiaries 12

Section 2-Company Analysis 13

Company Overview 13

SPI Pharma Inc-Business Description 14

SPI Pharma Inc-SWOT Analysis 15

SWOT Analysis-Overview 15

SPI Pharma Inc-Strengths 15

SPI Pharma Inc-Weaknesses 16

SPI Pharma Inc-Opportunities 17

SPI Pharma Inc-Threats 18

SPI Pharma Inc-Key Competitors 19

Section 3-Company's Lifesciences Financial Deals and Alliances 20

SPI Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 20

SPI Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 21

SPI Pharma Inc, Recent Deals Summary 22

Section 4-Company's Recent Developments 23

Oct 09, 2018: SPI Pharma launches Mannogem XL mannitol, enabling production of difficult-to-compress and problematic formulations 23

Section 5-Appendix 24

Methodology 24

About GlobalData 24

Contact Us 24

Disclaimer 24


List Of Figure

List of Figures

SPI Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 20

SPI Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019 21


List Of Table

List of Tables

SPI Pharma Inc, Key Facts 5

SPI Pharma Inc, Key Employees 6

SPI Pharma Inc, Major Products and Services 7

SPI Pharma Inc, History 10

SPI Pharma Inc, Other Locations 12

SPI Pharma Inc, Subsidiaries 12

SPI Pharma Inc, Key Competitors 19

SPI Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 20

SPI Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 21

SPI Pharma Inc, Recent Deals Summary 22

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

T2 Biosystems Inc

StrataGent Life Sciences, Inc.

Sierra Neuropharmaceuticals Inc

Siemens Healthineers AG

PharmaJet Inc

JRS PHARMA GmbH & Co KG

Biddle Sawyer Corp